CenterWatch
  • Search Clinical Trials
  • Clinical Trial Listings
  • Volunteer
  • Learn About Clinical Trials

Lorca (murcia), Spain

< 2 Miles
Filters

Type

Distance
Age
0
0
Gender
Trial Phase
Sponsor
  • Long Acting Cabotegravir Plus Rilpivirine in People Living with HIV-1 Aged ≥ 60 Years for 24 Months.

    Phase

    4

    Span

    100 weeks

    Sponsor

    Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia

    Lorca, Murcia

    Recruiting

  • Impact of the HELPeN Program on Social Isolation in Community-dwelling Elders (HELPeN)

    Phase

    N/A

    Span

    161 weeks

    Sponsor

    MARIA RUZAFA MARTINEZ

    Lorca, Murcia

    Recruiting

  • Computerized Registry of Patients With Venous Thromboembolism (RIETE)

    The RIETE Registry pretends the improvement of care of patients with thromboembolic disease. Very often the investigators pose serious doubts on how to manage a specific patient. Sometimes because it is a patient with thrombocytopenia, a pregnant woman, a patient with a recent cerebral bleeding or cerebral metastasis, a patient with gastroduodenal ulcer or hepatic cirrhosis. There is no clinical evidence about how the investigators should manage these patients and the investigators have to individualize its management. The bibliography available is not of much help. Only if the investigators have a database with a sufficient number of cases, they may be able to make evidence based decisions. This database on the Internet will allow the investigators to consult and obtain an immediate response when taking care of a patient who needs an individualized management. After introducing the patient the investigators will automatically obtain the data of all patients with similar clinical profiles. And this will help the investigators to identify high-risk patients and thus facilitate them preventing possible future complications.

    Phase

    N/A

    Span

    1401 weeks

    Sponsor

    Manuel Monreal

    Lorca, Murcia

    Recruiting

  • An Ex-US Study to Assess Treatment Persistence With Risankizumab in Adult Participants With Psoriatic Arthritis

    Phase

    N/A

    Span

    213 weeks

    Sponsor

    AbbVie

    Lorca, Murcia

    Recruiting

1-4 of 4
CenterWatch

5000 Centregreen Way, Suite 200
Cary, NC, 27513, USA

Phone: 703.538.7600
Toll Free: 888.838.5578

  • Disclaimer
  • Privacy Policy
  • Term of Use
  • Do Not Sell My Personal Information